Pro-tumorigenic effects of NF-κB also occur in colorectal cancer, head and neck squamous cell carcinoma (HNSCC), glioblastoma, Hodgkin’s disease, hepatitis-associated hepatocellular carcinoma and multiple myeloma29, 30. This evidence concerns the gene NFKB1 and head and neck squamous cell carcinoma.